BENEO, a leading manufacturer of functional ingredients for food, feed and pharma, and WACKER, a European expert in biotechnology solutions for the food and pharma industry, are set to launch the human milk oligosaccharide (HMO) 2’-Fucosyllactose (2’-FL) globally.
It is the predominant and most extensively studied HMO and will be available to the European market in the coming weeks. The product launch is the first result of a strategic and global partnership to enhancing early-life nutrition.
Within the partnership WACKER will oversee the production leveraging its reputable expertise in biotechnology. It will produce 2’-FL in Europe using precision fermentation via a patented strain. BENEO will be responsible for the commercialisation, making the most of its comprehensive knowledge in scientific research as well as of the global market for infant nutrition.
Olivier Roques, CEO at BENEO said, “The launch of 2’-FL and the associated addition of HMOs to BENEO’s established and well recognized portfolio of scientifically proven prebiotics is strategic. Particularly for the infant nutrition market, it provides promising opportunities for highly effective combinations. We are pleased about the collaboration with such an experienced partner like WACKER and are looking forward to the joint journey for HMOs.”
Mathias Wiedemann, President of WACKER Biosolutions said, “We are excited about this new partnership. It will bring together WACKER’s expertise and production track record with BENEO’s thorough market understanding. Together, we are set to meet the high demands of customers in the infant nutrition sector.”
The global demand for HMOs is expected to grow significantly, from around US$180 million in 2022 to almost US$900 million by 2032, reflecting a CAGR of more than 17%[i]. This predicted growth is supported by an increasing number of infant-formula product launches featuring HMOs, which rose from 4% to 20% between 2018 and 2023[ii]. This growing prevalence further underscores the critical role and market demand for HMOs.
i Spherical Insights (2023). [online] Available at: https://www.globenewswire.com/news-release/2023/12/06/2791573/0/en/Global-Human-Milk Oligosaccharides-HMO-Market-Size-To-Exceed-USD-896-91-Million-By-2032-CAGR-of-17-34.html
ii Mintel GNPD 2024
For more information, click on:
Wacker Chemicals (South Asia) Pte Ltd
